These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 21143042)

  • 1. Design, synthesis, and biological activity of thiazole derivatives as novel influenza neuraminidase inhibitors.
    Liu Y; Zhang L; Gong J; Fang H; Liu A; Du G; Xu W
    J Enzyme Inhib Med Chem; 2011 Aug; 26(4):506-13. PubMed ID: 21143042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors.
    Liu Y; Jing F; Xu Y; Xie Y; Shi F; Fang H; Li M; Xu W
    Bioorg Med Chem; 2011 Apr; 19(7):2342-8. PubMed ID: 21382719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, inhibitory activity, and SAR studies of hydrophobic p-aminosalicylic acid derivatives as neuraminidase inhibitors.
    Zhang J; Wang Q; Fang H; Xu W; Liu A; Du G
    Bioorg Med Chem; 2008 Apr; 16(7):3839-47. PubMed ID: 18304821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, inhibitory activity, and SAR studies of pyrrolidine derivatives as neuraminidase inhibitors.
    Zhang J; Wang Q; Fang H; Xu W; Liu A; Du G
    Bioorg Med Chem; 2007 Apr; 15(7):2749-58. PubMed ID: 17287121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors.
    Xiao M; Xu L; Lin D; Lian W; Cui M; Zhang M; Yan X; Li S; Zhao J; Ye J; Liu A; Hu A
    Eur J Med Chem; 2021 Mar; 213():113161. PubMed ID: 33540229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of acylguanidine zanamivir derivatives as neuraminidase inhibitors and the evaluation of their bio-activities.
    Lin CH; Chang TC; Das A; Fang MY; Hung HC; Hsu KC; Yang JM; von Itzstein M; Mong KK; Hsu TA; Lin CC
    Org Biomol Chem; 2013 Jun; 11(24):3943-8. PubMed ID: 23695381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and anti-influenza viral activities of 1,3-diarylprop-2-en-1-ones: a novel class of neuraminidase inhibitors.
    Kinger M; Park YD; Park JH; Hur MG; Jeong HJ; Park SJ; Lee WS; Kim SW; Yang SD
    Arch Pharm Res; 2012 Mar; 35(4):633-8. PubMed ID: 22553055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of 4-alkyl-2-amino(acetamino)-6-aryl-1,3-thiazine derivatives as influenza neuraminidase inhibitors.
    Li W; Xia L; Hu A; Liu A; Peng J; Tan W
    Arch Pharm (Weinheim); 2013 Sep; 346(9):635-44. PubMed ID: 23926081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and preliminary evaluation of new pyrrolidine derivatives as neuraminidase inhibitors.
    Zhang J; Xu W; Liu A; Du G
    Med Chem; 2008 May; 4(3):206-9. PubMed ID: 18473912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of 6-oxo-1,4,5,6-tetrahydropyrimidine-5-carboxylate derivatives as neuraminidase inhibitors.
    Lou J; Yang X; Rao Z; Qi W; Li J; Wang H; Li Y; Li J; Wang Z; Hu X; Liu P; Hong X
    Eur J Med Chem; 2014 Aug; 83():466-73. PubMed ID: 24992074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.
    Li Z; Meng Y; Xu S; Shen W; Meng Z; Wang Z; Ding G; Huang W; Xiao W; Xu J
    Bioorg Med Chem; 2017 May; 25(10):2772-2781. PubMed ID: 28385598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
    Chand P; Babu YS; Bantia S; Chu N; Cole LB; Kotian PL; Laver WG; Montgomery JA; Pathak VP; Petty SL; Shrout DP; Walsh DA; Walsh GM
    J Med Chem; 1997 Dec; 40(25):4030-52. PubMed ID: 9406595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and one-pot synthesis of 2-thiazolylhydrazone derivatives as influenza neuraminidase inhibitors.
    Yuan K; Xiao M; Tan Y; Ye J; Xie Y; Sun X; Hu A; Lian W; Liu A
    Mol Divers; 2017 Aug; 21(3):565-576. PubMed ID: 28536876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.
    Xie Y; Xu D; Huang B; Ma X; Qi W; Shi F; Liu X; Zhang Y; Xu W
    J Med Chem; 2014 Oct; 57(20):8445-58. PubMed ID: 25255388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D QSAR and docking study of flavone derivatives as potent inhibitors of influenza H1N1 virus neuraminidase.
    Gao L; Zu M; Wu S; Liu AL; Du GH
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5964-70. PubMed ID: 21843936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes.
    Abed Y; Nehmé B; Baz M; Boivin G
    Antiviral Res; 2008 Feb; 77(2):163-6. PubMed ID: 17919743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further discovery of caffeic acid derivatives as novel influenza neuraminidase inhibitors.
    Xie Y; Huang B; Yu K; Xu W
    Bioorg Med Chem; 2013 Dec; 21(24):7715-23. PubMed ID: 24262883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arylazolyl(azinyl)thioacetanilide. Part 9: Synthesis and biological investigation of thiazolylthioacetamides derivatives as a novel class of potential antiviral agents.
    Zhan P; Wang L; Liu H; Chen X; Li X; Jiang X; Zhang Q; Liu X; Pannecouque C; Naesens L; De Clercq E; Liu A; Du G
    Arch Pharm Res; 2012 Jun; 35(6):975-86. PubMed ID: 22870806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a non-zwitterionic oseltamivir analogue as a potent influenza a neuraminidase inhibitor.
    Zhang H; Wang K; Zhu H; Zhao X; Zhao H; Lei Z; Chen B; Yang F; Liu K; Zhang K; Wang J; Tian Y
    Eur J Med Chem; 2020 Aug; 200():112423. PubMed ID: 32512482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: Design, synthesis, biological evaluation, ADME prediction and molecular docking studies.
    Ye J; Yang X; Xu M; Chan PK; Ma C
    Eur J Med Chem; 2019 Nov; 182():111635. PubMed ID: 31493744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.